extractX Ltd. (“extractX” or the “Company”), is a pioneering, turnkey, data-driven builder designer of mobile extraction labs, with Extraction-as-a-Service business model, for the botanical and pharmaceutical industries. We provide industrial-scale, Pharma-Grade mobile extraction labs that can be deployed on-site at a partner’s facility with minimal capital expenditure (CAPEX) for the partner.

extractX has partnered with Canurta, a biotech innovator that has developed novel methods to identify, extract, and enrich rare polyphenolic molecules, to expand its lab capabilities, the EML 2.0 to capture high-value plant compounds (including unique polyphenols and flavonoids) that have been previously unexplored, allowing for the generation of brand new, diversified revenue streams that materially reduce reliance on the emerging yet inconsistent global cannabinoid market – this new version of our proven Lab is a true Game Changer.

While extractX labs are already optimized for the highest quality extraction, we are enhancing the lab configuration to capture rare plant polyphenols such as cannflavins. Typically, these valuable compounds are present in trace amounts in various botanical biomasses and in many cases are difficult and costly to extract. By working with Canurta and leveraging their patented extraction processes, and unique know-how, our latest EML 2.0 labs provide the ability to also extract these high-value molecules, creating additional revenue streams for partners, without requiring additional costly processes.

“This extractX – Canurta partnership, allows are global processing partners lead in their market in discovering and delivering new natural products. This capability is especially compelling for pharmaceutical and nutraceutical companies seeking differentiated, IP-protected ingredients derived from nature,” stated Albert Iannantuono, CEO of extractX Ltd.

Akeem Gardner, CEO Canurta says “The vision for this initiative is inherently global. Health and wellness markets around the world are trending toward natural and plant-based solutions, and regulatory shifts such as cannabis rescheduling in the US, are opening new avenues for polyphenol-rich extracts in medicine. extractX’s mobile labs are designed to meet international standards, enabling their partners to have unique advantages as they in the EML 2.0 abilities to produce Canurta products.”

“We developed a whitepaper that dives into the science, infrastructure, and business model behind EML 2.0, revealing how partners can capture high-value polyphenols without heavy capital investment” said Albert Iannantuono CEO.

Whitepaper can be found here Unlocking High Value Natural Molecules with the extractX – Mobile Extraction Labs 2.0

Albert Iannantuono, CEO
extractX Ltd.
129 Hagar Street, Unit 4 Suite 600, Welland, ON L3B 5V9
905-327-5313